Clinical Trials

Showing trials with last updates posted in 2026.

NCT03228537 | ACTIVE_NOT_RECRUITING | PHASE1
28 participants

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2018-07-16
Completion:
2022-10-01
Conditions
  • Biphasic Mesothelioma
  • Epithelioid Mesothelioma
  • Stage I Pleural Diffuse Malignant Mesothelioma AJCC v7
  • Stage IA Pleural Diffuse Malignant Mesothelioma AJCC v7
  • Stage IB Pleural Diffuse Malignant Mesothelioma AJCC v7
  • Stage II Pleural Diffuse Malignant Mesothelioma AJCC v7
  • Stage III Pleural Diffuse Malignant Mesothelioma AJCC v7
Interventions
  • DRUG
  • PROCEDURE
  • RADIATION
NCT02698293 | WITHDRAWN | PHASE1
0 participants

PDT Plus Vitamin D3 for Anal Dysplasia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2019-12-01
Completion:
2022-08-03
Conditions
  • Anal Dysplasia
  • Carcinoma in Situ
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02610465 | COMPLETED
148 participants

High Image Matrix CT Reconstruction

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-04
Start Date:
2015-11-09
Completion:
2020-03-27
Conditions
  • Healthy Subjects
  • Pulmonary-Related Conditions
  • Cardiac-Related Conditions
No Results Yet
NCT02143414 | ACTIVE_NOT_RECRUITING | PHASE2
53 participants

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2015-06-30
Completion:
2022-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
NCT02115282 | ACTIVE_NOT_RECRUITING | PHASE3
608 participants

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2014-03-29
Completion:
2020-05-05
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Breast Adenocarcinoma
  • HER2/Neu Negative
  • Locally Advanced Breast Carcinoma
  • Metastatic Breast Carcinoma
  • Recurrent Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
NCT02101788 | COMPLETED | PHASE2/PHASE3
260 participants

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2014-04-11
Completion:
2019-04-04
Conditions
  • Borderline Ovarian Serous Tumor
  • Micropapillary Serous Carcinoma
  • Ovarian Serous Adenocarcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Recurrent Ovarian Low Grade Serous Adenocarcinoma
  • Recurrent Primary Peritoneal Serous Adenocarcinoma
Interventions
  • DRUG
  • OTHER
NCT01386385 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
53 participants

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2011-06-20
Completion:
2019-05-26
Conditions
  • Lung Adenocarcinoma
  • Lung Adenocarcinoma, Mixed Subtype
  • Lung Large Cell Carcinoma
  • Lung Squamous Cell Carcinoma
  • Minimally Invasive Lung Adenocarcinoma
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Interventions
  • RADIATION
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page